Texas NORML

Wed, 27 Jan 2010 22:39:15 By: Paul Armentano, NORML Deputy Director

It’s the ‘Catch-22’ that has plagued medical marijuana advocates and patients for decades. Lawmakers and health regulators demand clinical studies on the safety and efficacy of medical cannabis, but the federal agency in charge of such research bars these investigations from ever taking place.

But it took until now for the federal government to finally admit it.

A spokesperson for the U.S. National Institute on Drug Abuse (NIDA) told The New York Times last week that the agency does “not fund research focused on the potential medical benefits of marijuana.”

Why is this admission so significant? Here’s why.

Under federal law, NIDA (along with the U.S. Drug Enforcement Administration) must approve all clinical and preclinical research involving marijuana. NIDA strictly controls which investigators are allowed access to the federal government’s lone research supply of pot – which is authorized via a NIDA contract and cultivated and stored at the University of Mississippi.

In short, no NIDA approval = no marijuana = no scientific studies. And that is, and always has been, the problem.

But to the folks over at NIDA, there’s no problem at all.

Speaking to The New York Times in a January 19, 2010 article entitled, “Researchers Find Medical Study of Marijuana Discouraged,” NIDA spokeswoman Shirley Simson said: “As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana.”

Since NIDA presently oversees an estimated 85 percent of the world’s research on controlled substances, the agency’s ban on medical marijuana research isn’t just limited to the United States’ borders; it extends throughout the planet.

Previous legal attempts to break NIDA’s bureaucratic logjam have failed to weaken the agency’s iron grip.

In 2007, U.S. DEA Administrative Law Judge Mary Ellen Bittner ruled that NIDA’s monopolization of marijuana research is not “in the public interest,” and ordered the federal government to allow private manufacturers to produce the drug for research purposes. But in January of last year, DEA Deputy Administrator Michele Leonhart set aside Judge Bittner’s ruling – stating that NIDA possesses “adequate” quantities of cannabis to meet the needs of clinical investigators, and that the agency monopoly on the distribution of marijuana for research is compliant with America’s international treaty obligations. (Notably, on January 26, 2010 President Barack Obama selected Leonhart to be the DEA’s full time Director.)

Most recently, in November 2009 the American Medical Association’s (AMA) Council on Science and Public Health declared, “Results of short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis.”

However, the Council lamented that despite these encouraging preliminary results, “[T]here is a contrast between the relatively small number of patients who have been studied over the past 30 years in controlled clinical trials involving smoked cannabis and survey data from patients with chronic pain, multiple sclerosis, and amyotrophic lateral sclerosis that indicates a significant use of cannabis for self management.”

And just what is the precise reason for this “contrast?” The AMA failed to specify, but to anyone who has followed this issue, the answer is painfully obvious.

Nevertheless, the AMA still resolved, “[The] AMA urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines.”

But since any future clinical trials would still require NIDA approval — approval that the agency admits won’t be coming any time soon — it remains unclear what effect, if any, the AMA’s declaration will have on facilitating medical marijuana research. If history is any guide, it’s unlikely that the AMA request — much like the cries of tens of thousands of patients before it — will have any effect on NIDA at all.

Marc Katz pushes for legalization of medical marijuana in Texas

January 14, 2010 – Austin, TX - Marc Katz, candidate for lieutenant governor of Texas announced today that it is time for Texas to move towards the legalization of marijuana for medical use. After the US Supreme Court affirmed states’ rights to medical marijuana in May of 2009, many states have begun to openly debate the issue.

“We should summon the same humanity that many other states have and aggressively move towards the legalization of marijuana for medical use,” said Marc Katz, candidate for lieutenant governor of Texas, democratic ticket. “Even New Jersey is working on this, so why can’t Texas?”

“Our organization would like to see the next bill that comes out of the Texas legislature to not only protect patients who are caught by law, but make provisions for patients to either grow their own medicine or allow caregivers to provide, like in so many other states,” said Josh Schimberg Executive Director of Texas NORML. “The reason for legalization of marijuana is that the patients who are in the most need are the patients who have the least ability to acquire their medicine. Patients should be allowed to provide themselves with the medicine that helps them with what they need.”

Most recently the state of New Jersey legalized medicinal use of marijuana with some of the strictest regulations in the nation. Many speculate that New Jersey is attempting to avoid a surge in medical marijuana dispensaries like California has reportedly seen. Last year Governor Schwarzenegger of California urged for a study on legalizing medicinal marijuana use to make up for budgetary shortfalls. New York is rumored to be the next state to legalize medical usage of cannabis.

Contact:
Stacey Hines
Communications Coordinator, Marc Katz for lieutenant governor of Texas campaign
512.762.4286
http://www.marckatzforltgov.com/

Thu, 07 Jan 2010 15:57:08 By: Paul Armentano, NORML Deputy Director

The National Organization for the Reform of Marijuana Laws (NORML), the nation’s oldest and most well respected grassroots marijuana law reform organization, is pleased to announce the launch of the NORML Women’s Alliance.

The NORML Women’s Alliance is a nonpartisan coalition of prominent, educated, successful, and geographically diverse professional women who believe that cannabis prohibition is a self-destructive and hypocritical policy that undermines the American family, sends a mixed and false message to our young people, and destroys the cherished principles of personal liberty and local self-government.

Says NORML Executive Director Allen St. Pierre: “The prominent role of women in the effort to end marijuana prohibition is pivotal, necessary, and long overdue. According to recent national opinion polls by Gallup and others, the dramatic rise in the public’s support of marijuana law reform is being driven primarily by an increase in support among America’s women. The NORML Women’s Alliance will bring a contemporary approach to the public policy debate, and will proudly represent the interests of modern, mainstream women who believe that the negative consequences of marijuana prohibition far outweigh any repercussions from marijuana consumption itself.”

Charter members of the NORML Women’s Alliance include: NORML Foundation chair and film producer Ann Druyan, attorney and political activist Jessica Corry, editor Shelby Sadler, best-selling author Barbara Ehrenreich, Beverly Hills NORML director Cheryl Shuman, NORML Foundation board member Jeralyn Merritt, Esq., cannabis activist and author Mikki Norris, Cannabis Action Network and Berkeley Patients Group founder Debby Goldsberry, NORML board member and director of Oregon NORML Madeline Martinez, law professor Marjorie Russell, and former ACLU president Nadine Strossen. This founding group of women also includes medical physicians, researchers, business leaders, editors, publishers, mothers, grandmothers, and great grandmothers.

The NORML Women’s Alliance holds the following positions:

1. The NORML Women’s Alliance believes that the fiscal priorities of marijuana prohibition are wasting billions of dollars on a failed policy.

2. The NORML Women’s Alliance believes that marijuana prohibition violates states’ rights, and improperly expands the reach of government into the families and personal lives of otherwise law-abiding citizens.

5. The NORML Women’s Alliance strongly opposes the sexual exploitation and objectification of women in pot-culture and business marketing.

“A marijuana policy that fosters children selling marijuana en mass must immediately change and be replaced by one that effectively stops children from trafficking in marijuana,” says Sabrina Fendrick, coordinator of the NORML Women’s Alliance. “The NORML Women’s Alliance seeks to replace a failed, tax coffer-draining and child endangering 73-year old cannabis prohibition with functional, tax-producing and youth-friendly cannabis policies consisting of legal and social controls that are not at all dissimilar to our existing and ever-evolving alcohol policies.”

Further information about the NORML Women’s Alliance is available online here.

December 30th, 2009 By: Russ Belville, NORML Outreach Coordinator

(Courthouse News Service) – Two North Dakota farmers failed to convince the 8th Circuit that cannabis grown for industrial hemp is not technically marijuana and should not be regulated under federal law.

The court in St. Louis upheld dismissal of the farmers’ lawsuit seeking a declaration that the Controlled Substances Act (CSA) does not apply to industrial-use cannabis.

The appeals court pointed out that the Act defines marijuana to include all cannabis plants, regardless of the THC concentration.

“The CSA likewise makes no distinction between cannabis grown for drug use and that grown for industrial use,” Judge Pasco Bowman wrote.

The three-judge panel rejected the notion that industrial hemp is not marijuana under the Act, or that Congress has no authority to regulate their state-sanctioned cultivation of cannabis.

Judge Bowman said Congress had a “rational basis” for regulating the cultivation of all cannabis plants in order to effectively regulate marijuana.

The “rational basis” here is that North Dakota farmers can’t grow tall, reedy hemp plants that could never ever get anyone high, because that will confuse the law enforcement officials who are working to eradicate short bushy cannabis plants that are grown to get people high. Somehow, in Australia, Canada, and China to name a few countries, police who are tasked with eradicating illegal cannabis in those countries that have legal hemp have no difficulty whatsoever distinguishing the two crops, but American police are just baffled by basic agriculture.

Silly as it sounds, that’s the court’s argument. We’d never be able to “effectively regulate marijuana” if farmers were growing hemp. Not that we’re actually “effectively regulating marijuana” now. Prohibition of marijuana is the absence of regulation — no regulations on who can buy it, who can sell it, where it can be sold, what age you must be to purchase it, where it can be used, what THC potency is allowed, whether the crop can be grown with certain pesticides and fertilizers, and what penalties should be leveled for failure to follow the regulations. Yes, there are laws against marijuana that makes all of those actions a crime, but by definition you can only regulate something that is legal.

Prohibition doesn’t make those actions go away, it just makes them crimes. Therefore, those actions are occurring in an unregulated manner. So how is it, again, that growing an industrial hemp plant is preventing the government from regulating something that prohibition made unregulated?

#1 Obama Administration: Don’t Focus On Medical Marijuana Prosecutions
United States Deputy Attorney General David Ogden issued a memorandum to federal prosecutors in October directing them to not “focus federal resources … on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.” The directive upheld a campaign promise by President Barack Obama, who had previously pledged that he was “not going to be using Justice Department resources to try to circumvent state laws on this issue.” Read the full story at: http://norml.org/index.cfm?Group_ID=7998.

#2 Public Support For Legalizing Pot Hits All-Time High
A majority of likely voters now support legalizing marijuana, according to a national poll of 1,004 likely voters published in December by Angus Reid. The Angus Reid Public Opinion poll results echo those of separate national polls conducted this year by Gallup, Zogby, ABC News, CBS News, Rasmussen Reports, and the California Field Poll each of which reported greater public support for marijuana legalization than ever before. Read the full story at: http://norml.org/index.cfm?Group_ID=8054.

#3 Lifetime Marijuana Use Associated With Reduced Cancer Risk
The moderate long-term use of cannabis is associated with a reduced risk of head and neck cancer, according to the results of a population-based control study published in August by the journal Cancer Prevention Research. Authors reported, “After adjusting for potential confounders (including smoking and alcohol drinking), 10 to 20 years of marijuana use was associated with a significantly reduced risk of head and neck squamous cell carcinoma.” Read the full story at: http://norml.org/index.cfm?Group_ID=7944.

#4 AMA Calls For Review Of Marijuana’s Prohibitive Status
In November, the American Medical Association resolved that marijuana should longer be classified as a Schedule I prohibited substance. Drugs classified in Schedule I are defined as possessing “no currently accepted use in treatment in the United States.” In a separate action, the AMA also determined, “Results of short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis.” Read the full story at: http://norml.org/index.cfm?Group_ID=8020.

#5 California: Lawmakers Hold Historic Hearing On Marijuana Legalization
State lawmakers heard testimony in October in support of taxing and regulating the commercial production and distribution of cannabis for adults age 21 and older. Additional hearings, as well as a vote on Assembly Bill 390: the Marijuana Control, Regulation, and Education Act, are scheduled for January 2010. Read the full story at: http://norml.org/index.cfm?Group_ID=8002.

#6 Maine Voters Approve Medical Marijuana Dispensaries Measure; Dispensaries Coming To Washington, DC In 2010
Voters in November decided in favor of a statewide measure that allows for the state to license non-profit facilities to distribute medical cannabis to qualified patients. The vote marked the first time that citizens ever approved a statewide ballot proposal authorizing the creation of dispensaries. In June, Rhode Island lawmakers enacted a similar measure. In December, Congress lifted federal restrictions to allow for the DC City Council to implement provisions of a ten-year-old medical marijuana law that would allow for the use and distribution of medicinal cannabis in the District of Columbia. Read the full story at: http://norml.org/index.cfm?Group_ID=8011.

#7 Oakland: Voters Approve First-In-The-Nation Medical Marijuana Business Tax
In July 80 percent of municipal voters approved Ballot Measure F, the nation’s first ever business tax on the retail sales of cannabis. The tax, which takes effect on January 1, imposes an exclusive tax for “cannabis businesses” of $18 for every $1,000 of gross receipts. Read the full story at: http://norml.org/index.cfm?Group_ID=7937.

#8 Rasmussen Poll: Majority Of Americans Say Marijuana Is Safer Than Alcohol
More than half of American adults believe that alcohol is “more dangerous” than marijuana, according to the results of a national telephone poll of 1,000 likely voters published in September by Rasmussen Reports. Fifty-one percent of respondents, including a majority of women, rated the use of marijuana to be less dangerous than alcohol. Only 19 percent of those polled said that cannabis is the more dangerous of the two substances. Read the full story at: http://norml.org/index.cfm?Group_ID=7965.

#9 Many Teens See Medical Cannabis As Alternative Treatment Option
Some one-third of adolescents view their use of marijuana as therapeutic rather than recreational, according to survey data published in May by the journal Substance Abuse, Treatment, Prevention and Policy. Teens most commonly reported using cannabis therapeutically to counter symptoms of depression, stress and anxiety, attention deficit hyperactivity disorder (ADHD), physical pain, and sleeplessness. In November several mainstream media outlets, including The New York Times and Good Morning America, featured stories on adolescents using marijuana as a medicine. Read the full story at: http://norml.org/index.cfm?Group_ID=7864.

#10 Oregon NORML Opens ‘Cannabis Café,’ Media Frenzy Follows
In November Oregon NORML opened the state’s first café catering to state-authorized medical marijuana patients. Unlike conventional marijuana dispensaries that operate in states like California and Colorado, medical cannabis is not sold on the premises, nor is the primary function of the café to dispense marijuana. “This is not a medical marijuana dispensary with a café; this is a café for medical marijuana patients,” said Madeline Martinez, Oregon NORML Executive Director. The Associated Press, Reuters, USA Today, The New York Times, and Democracy Now were among the hundreds of media outlets that covered the story. Read the full story at: http://norml.org/index.cfm?Group_ID=8024.

Many people have high hopes for 2010.